Oncology – Arenis Medico https://arenismedico.eu Tue, 12 Jan 2021 21:16:47 +0000 es hourly 1 https://wordpress.org/?v=5.6.13 https://arenismedico.eu/wp-content/uploads/2021/02/favicons.png Oncology – Arenis Medico https://arenismedico.eu 32 32 Tamoxibol — 10mg Tamoxifen Citrate https://arenismedico.eu/product/tamoxibol-10mg-tamoxifen-citrate/ Tue, 12 Jan 2021 21:11:50 +0000 https://arenismedico.eu/?post_type=product&p=541 Tamoxibol (Tamoxifen Citrate) is a non-steroidal anti-estrogenic drug, used widely in clinical medicine. It is specifically a Selective Estrogen-Receptor Modulator (SERM) of the triphenylethylene family, and possesses both estrogen agonist and antagonist properties. Tamoxibol (Tamoxifen Citrate) is a strong anti-estrogen in breast tissue, and as a result it is commonly used in the treatment of hormone-responsive breast cancer in women. In male bodybuilders and athletes, Tamoxibol (Tamoxifen Citrate) is commonly used to counter the side effects caused by elevated estrogens subsequent to the use of certain anabolic/androgenic steroids. Since anabolic/androgenic steroids tend to suppress endogenous testosterone production, Tamoxibol (Tamoxifen Citrate) can help restore a balance in hormone levels. It is most commonly used as part of a comprehensive post cycle recovery program.

Side Effects

Common side effects associated with the administration of Tamoxibol (Tamoxifen Citrate) include hot flashes, vaginal bleeding, vaginal discharge, vaginal itching, upset stomach, headache, lightheadedness, edema, and hair loss. Other listed adverse reactions include skin rash, reduced platelet or white blood cell count, visual disturbances, uterine fibroids, endometriosis and other endometrial changes, deep vein thrombosis and pulmonary embolism, changes in liver enzyme levels, and increased triglyceride levels. An increased incidence of endometrial cancer and uterine sarcoma has been reported in association with Tamoxibol (Tamoxifen Citrate). Tamoxibol (Tamoxifen Citrate) may cause birth defects and should not be taken during pregnancy.

Administration

To mitigate the estrogenic effects of anabolic/androgenic steroid use, a daily dosage of 10-30 mg (1-3 tablets) is usually administered while any offending steroids are taken, or as part of a comprehensive post-cycle hormone recovery program. It is important to note that anti-estrogen use may slightly reduce gains made during a steroid cycle, as many androgenic/anabolic steroids seem to exhibit their most powerful anabolic effects when accompanied by a sufficient level of estrogen.
]]> Tamoxibol (Tamoxifen Citrate) is a non-steroidal anti-estrogenic drug, used widely in clinical medicine. It is specifically a Selective Estrogen-Receptor Modulator (SERM) of the triphenylethylene family, and possesses both estrogen agonist and antagonist properties. Tamoxibol (Tamoxifen Citrate) is a strong anti-estrogen in breast tissue, and as a result it is commonly used in the treatment of hormone-responsive breast cancer in women. In male bodybuilders and athletes, Tamoxibol (Tamoxifen Citrate) is commonly used to counter the side effects caused by elevated estrogens subsequent to the use of certain anabolic/androgenic steroids. Since anabolic/androgenic steroids tend to suppress endogenous testosterone production, Tamoxibol (Tamoxifen Citrate) can help restore a balance in hormone levels. It is most commonly used as part of a comprehensive post cycle recovery program.

Side Effects

Common side effects associated with the administration of Tamoxibol (Tamoxifen Citrate) include hot flashes, vaginal bleeding, vaginal discharge, vaginal itching, upset stomach, headache, lightheadedness, edema, and hair loss. Other listed adverse reactions include skin rash, reduced platelet or white blood cell count, visual disturbances, uterine fibroids, endometriosis and other endometrial changes, deep vein thrombosis and pulmonary embolism, changes in liver enzyme levels, and increased triglyceride levels. An increased incidence of endometrial cancer and uterine sarcoma has been reported in association with Tamoxibol (Tamoxifen Citrate). Tamoxibol (Tamoxifen Citrate) may cause birth defects and should not be taken during pregnancy.

Administration

To mitigate the estrogenic effects of anabolic/androgenic steroid use, a daily dosage of 10-30 mg (1-3 tablets) is usually administered while any offending steroids are taken, or as part of a comprehensive post-cycle hormone recovery program. It is important to note that anti-estrogen use may slightly reduce gains made during a steroid cycle, as many androgenic/anabolic steroids seem to exhibit their most powerful anabolic effects when accompanied by a sufficient level of estrogen.
]]> Letrobol — 2.5mg Letrozole https://arenismedico.eu/product/letrobol-2-5mg-letrozole/ Tue, 12 Jan 2021 21:10:20 +0000 https://arenismedico.eu/?post_type=product&p=539 Letrobol (Letrozole) is a non-steroidal selective third generation aromatase inhibitor used for the treatment of postmenopausal women with estrogen receptor-positive or estrogen receptor-unknown breast cancer. Letrobol (Letrozole) is highly favored by athletes for its ability to mitigate the estrogenic side effects associated with the use of aromatizable anabolic/androgenic steroids, such as gynecomastia, fat buildup, and visible water retention.

Side Effects

Common side effects associated with the use of an aromatase inhibitor include hot flashes, joint pain, weakness, fatigue, mood changes, depression, high blood pressure, swelling of the arms/ legs, and headache. Aromatase inhibitors may also decrease bone mineral density, which may lead to osteoporosis and an increase in fractures in susceptible patients. Some individuals may also respond to the medication with gastrointestinal side effects including nausea and vomiting. Aromatase inhibitors can harm the development of an unborn fetus, and should never be taken or handled during pregnancy. When taken by men to reduce estrogenicity during prolonged periods of steroid treatment, aromatase inhibitors may increase cardiovascular disease (CVD) risk by retarding some beneficial properties of estrogen on cholesterol values. Studies have demonstrated that when an aromatizable steroid such as testosterone enanthate is taken in conjunction with an aromatase inhibitor, suppression of HDL (good) cholesterol levels become significantly more pronounced.

Administration

To mitigate the estrogenic effects of anabolic/androgenic steroid use, a daily dosage of 1.25-2.5mg administered once per day, without regard to meals. In some cases a dosage of a half of a tablet (1.25 mg) taken every other day is sufficient to prevent the onset of estrogenic side effects.
]]> Letrobol (Letrozole) is a non-steroidal selective third generation aromatase inhibitor used for the treatment of postmenopausal women with estrogen receptor-positive or estrogen receptor-unknown breast cancer. Letrobol (Letrozole) is highly favored by athletes for its ability to mitigate the estrogenic side effects associated with the use of aromatizable anabolic/androgenic steroids, such as gynecomastia, fat buildup, and visible water retention.

Side Effects

Common side effects associated with the use of an aromatase inhibitor include hot flashes, joint pain, weakness, fatigue, mood changes, depression, high blood pressure, swelling of the arms/ legs, and headache. Aromatase inhibitors may also decrease bone mineral density, which may lead to osteoporosis and an increase in fractures in susceptible patients. Some individuals may also respond to the medication with gastrointestinal side effects including nausea and vomiting. Aromatase inhibitors can harm the development of an unborn fetus, and should never be taken or handled during pregnancy. When taken by men to reduce estrogenicity during prolonged periods of steroid treatment, aromatase inhibitors may increase cardiovascular disease (CVD) risk by retarding some beneficial properties of estrogen on cholesterol values. Studies have demonstrated that when an aromatizable steroid such as testosterone enanthate is taken in conjunction with an aromatase inhibitor, suppression of HDL (good) cholesterol levels become significantly more pronounced.

Administration

To mitigate the estrogenic effects of anabolic/androgenic steroid use, a daily dosage of 1.25-2.5mg administered once per day, without regard to meals. In some cases a dosage of a half of a tablet (1.25 mg) taken every other day is sufficient to prevent the onset of estrogenic side effects.
]]> Anastrobol — 1mg Anastrozole https://arenismedico.eu/product/anastrobol-1mg-anastrozole/ Tue, 12 Jan 2021 21:08:11 +0000 https://arenismedico.eu/?post_type=product&p=537 Anastrobol (Anastrozole) is an anti-estrogenic drug developed for the treatment of advanced breast cancer in women. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen in the body. In male bodybuilders and athletes, Anastrobol (Anastrozole) is commonly used to counter the side effects caused by elevated estrogens subsequent to the use of certain anabolic/androgenic steroids.

Side Effects

Common side effects associated with the use of an aromatase inhibitor include hot flashes, joint pain, weakness, fatigue, mood changes, depression, high blood pressure, swelling of the arms/ legs, and headache. Aromatase inhibitors may also decrease bone mineral density, which may lead to osteoporosis and an increase in fractures in susceptible patients. Some individuals may also respond to the medication with gastrointestinal side effects including nausea and vomiting. Aromatase inhibitors can harm the development of an unborn fetus, and should never be taken or handled during pregnancy. When taken by men to reduce estrogenicity during prolonged periods of steroid treatment, aromatase inhibitors may increase cardiovascular disease (CVD) risk by retarding some beneficial properties of estrogen on cholesterol values. Studies have demonstrated that when an aromatizable steroid such as testosterone enanthate is taken in conjunction with an aromatase inhibitor, suppression of HDL (good) cholesterol levels become significantly more pronounced. Since the estrogen receptor agonist/antagonist Nolvadex generally does not display the same anti-estrogenic (negative) effect on cholesterol values, it is usually favored over aromatase inhibitors for estrogen maintenance by male bodybuilders and athletes concerned with cardiovascular health.

Administration

To mitigate the estrogenic side effects of anabolic/androgenic steroid use, male athletes and bodybuilders will commonly take 0.5 mg to 1 mg of Anastrobol (Anastrozole) per day. In some instances a half of a tablet (0.5 mg) taken every other day is sufficient to mitigate the buildup of estrogen. When used with readily aromatizing androgens such as methandrostenolone or testosterone, gynecomastia and water retention are often effectively blocked. Additionally, the use of Anastrobol (Anastrozole) may decrease fat mass, which can also be tied to estrogen levels. The result can be a harder and much more defined appearance to the muscles and physique, which makes this agent of interest for dieting/cutting purposes as well. Food does not appear to affect the absorption of Anastrobol (Anastrozole), so the drug may be taken with or between meals.
]]> Anastrobol (Anastrozole) is an anti-estrogenic drug developed for the treatment of advanced breast cancer in women. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen in the body. In male bodybuilders and athletes, Anastrobol (Anastrozole) is commonly used to counter the side effects caused by elevated estrogens subsequent to the use of certain anabolic/androgenic steroids.

Side Effects

Common side effects associated with the use of an aromatase inhibitor include hot flashes, joint pain, weakness, fatigue, mood changes, depression, high blood pressure, swelling of the arms/ legs, and headache. Aromatase inhibitors may also decrease bone mineral density, which may lead to osteoporosis and an increase in fractures in susceptible patients. Some individuals may also respond to the medication with gastrointestinal side effects including nausea and vomiting. Aromatase inhibitors can harm the development of an unborn fetus, and should never be taken or handled during pregnancy. When taken by men to reduce estrogenicity during prolonged periods of steroid treatment, aromatase inhibitors may increase cardiovascular disease (CVD) risk by retarding some beneficial properties of estrogen on cholesterol values. Studies have demonstrated that when an aromatizable steroid such as testosterone enanthate is taken in conjunction with an aromatase inhibitor, suppression of HDL (good) cholesterol levels become significantly more pronounced. Since the estrogen receptor agonist/antagonist Nolvadex generally does not display the same anti-estrogenic (negative) effect on cholesterol values, it is usually favored over aromatase inhibitors for estrogen maintenance by male bodybuilders and athletes concerned with cardiovascular health.

Administration

To mitigate the estrogenic side effects of anabolic/androgenic steroid use, male athletes and bodybuilders will commonly take 0.5 mg to 1 mg of Anastrobol (Anastrozole) per day. In some instances a half of a tablet (0.5 mg) taken every other day is sufficient to mitigate the buildup of estrogen. When used with readily aromatizing androgens such as methandrostenolone or testosterone, gynecomastia and water retention are often effectively blocked. Additionally, the use of Anastrobol (Anastrozole) may decrease fat mass, which can also be tied to estrogen levels. The result can be a harder and much more defined appearance to the muscles and physique, which makes this agent of interest for dieting/cutting purposes as well. Food does not appear to affect the absorption of Anastrobol (Anastrozole), so the drug may be taken with or between meals.
]]>